期刊文献+

长期使用低钙透析液对血液透析患者钙磷代谢的影响 被引量:3

Long-term dialysis with low-calcium solution in hemodialysis:effects on calcium phosphorus metabolism
下载PDF
导出
摘要 目的:研究应用钙离子1.25mmol/L透析液进行透析6个月对患者免疫反应性甲状旁腺素(iPTH)及钙磷水平的影响。方法:在规律性血透的患者中,选择透前或透后高钙血症的患者16例。入选前,所有患者均采用钙离子1.75mmol/L透析液,每周透析3次,每次4小时,均使用聚砜膜透析器,面积为1.3m2。使用钙离子1.25mmol/l(DCa1.25)透析液透析期间,患者饮食中钙磷的摄入量稳定,且根据需要伴高磷血症的患者同时口服碳酸钙(钙尔奇D),6个月。观察DCa1.25透析液单次治疗前、后至下一次透析前以及治疗1、2、3、6个月时患者透前血钙(校正的血清总钙)、血磷、iPTH水平(检测采用放免法)。结果:使用DCa1.25透析液单次透析4小时后血钙浓度下降,透后血iPTH(221.3±67)pg/ml较透前(163.7±78)pg/ml明显升高(P<0.05),至下次透析前血钙浓度及血iPTH(163.9±101.1)pg/ml基本恢复至上次透析前水平。使用低钙透析液透析1、2、3、6个月后,患者血钙水平呈下降趋势,在低钙透析2个月时,血钙水平显著低于治疗前水平(2.925±0.25)mmol/l,达(2.55±0.25)mmol/l,P<0.05,这种趋势持续至治疗6个月时,血钙水平(2.6±0.2)mmol/l,P<0.05。低钙透析对患者的iPTH水平有明显的影响,呈上升趋势,在低钙透析3个月时,差异有统计学意义,血iPTH上升至(294.4±134.1)pg/ml(P<0.05),低钙透析治疗6个月时,血iPTH达(295.5±192.3)pg/ml(P<0.05),所有患者均完成了6个月的临床观察,其中6名患者因治疗后的iPTH升高超过300pg/ml,而开始应用活性维生素D,有1例患者iPTH升高达821pg/ml,接受了活性维生素D的冲击治疗。血磷水平在进行低钙透析治疗后有所上升,但差异无统计学意义。结论:在维持性血液透析患者中,单次应用DCa1.25的透析液进行透析,透析后血iPTH升高,但至下一次透析前血iPTH基本恢复至上次透前水平。持续应用低钙透析6个月,钙负荷减轻,血iPTH升高。 Objective:To observe the change of intact parathyroid hormone,serum calcium and serum phosphorus in hemodialysis (HD) patients treated with the dialysate of low-calcium (1.25 mmol/1) for 6 months.Methods:Sixteen patients with hypercalcaemia per-or post-dialysis 3 times per week were enrolled in this study.All of them received hemodialysis with the dialysate of low-calcium (1.25 mmol/1) for 6 months.During this period,the patients maintained stablely for diet.Before and after using the low-calcium dialysate therapy, the serum calcium,phosphorus and intact parathyroid hormone were measured in pre-,post- and the next pre-dialysis.Results:For a single dialysis ,the serum calcium decreased in post-dialysis (2.805±0.2)mmol/1 compared with in pre-dialysis(2.925±0.25)mmol/1,and the iPTH increased significantly in post-dialysis compared with pre-dialysis [(221.3±67)pg/ml,vs (163.7±78)pg/ml,P〈0.05].However, the serum calci-um (2.93±0.24)mmol/1 and iPTH (163.9±101)pg/ml come back in the next pre-dialysis.When patients being dialyzed with the low-calcium dialysate (1.25mmol/1) for 6 months, the serum calcium decreased and the iPTH increased significandy in post-dialysis compared with pre-dialysis [(295.5±192.3)pg/ml vs (163.7±78)pg/ml,P〈0.05].Conclusion:When patients were dialyzed with the dialysate of low-calcium for 6 months, the serum iPTH might increase and the calaium decreased.The iPTH,calcium and phosphorus should be detected regularly if the low calcium dialysate (1.25mmol/l) was used for a long time.
出处 《现代医药卫生》 2006年第22期3417-3419,共3页 Journal of Modern Medicine & Health
关键词 血液透析 低钙透析液 钙磷代谢 Hemodialysis Low-calcium dialysate Calcium phosphours metabolism
  • 相关文献

参考文献6

  • 1Yokoyama K,Shigematus T,Kagami S,et al.Vitamin Dreceptor gene polymorphismdetected by digestion with Apo Ⅰ influence the parathyroid response to extracellular calcium in Japanese chronic dialysis patients[J].Nephron,2001,89(3):315. 被引量:1
  • 2Goodman WG,Goldin J,Kuizon BD,et al.comary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis[J].N Engi J med,2000,342:1478. 被引量:1
  • 3陈育青,王梅.低钙透析液对血甲状旁腺素及钙磷代谢的影响[J].肾脏病与透析肾移植杂志,2005,14(1):34-36. 被引量:30
  • 4刘俊铎,张阿芳,宋文利.低钙透析对尿毒症患者甲状旁腺功能的影响[J].中国血液净化,2004,3(2):85-86. 被引量:9
  • 5Young EW,Albert JM,Satayathum S,et al.predictors and consequences of altered mineral metabolism:The dialysis Outcomes and Practice Patterns Study[J].Kidney Int,2005,67:1179. 被引量:1
  • 6Locatell F.The need for better control of secondary parathyroedism[J].Nephrol Dial Trans,2005,19(5):15. 被引量:1

二级参考文献18

  • 1孙鲁英,左力,王梅.不同钙离子浓度透析液对血液透析患者钙平衡及甲状旁腺素的影响[J].中华肾脏病杂志,2004,20(3):210-213. 被引量:51
  • 2[1]Holgado R, Hairre h, Ross D, et al. Effects of low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis. J Bone miner Res, 2000,15;927-35 被引量:1
  • 3[2]Talmage RV, Roycroft JH, Anderson JJB. morphological considerations in new concept of calcium transport in bone. Am J Anat, 1975,129:467-476 被引量:1
  • 4[3]Fernandez E, Borras M, Pais B, et al. Low-cacium dialysis stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc nephrol, 1995,6:132-135 被引量:1
  • 5[4]Sherrard DJ, herca G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney int, 1993,43:436-442 被引量:1
  • 6[5]Yokoyama K, Shigematus T, Kagami S, et al. Vitamin D receptor gene polymorphism detected by digestion with Apo I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients. Nephron, 2001, Nov 89(3) 315-320 被引量:1
  • 7[6]Fabrizi F, Bacchini G, Di Filippo S. Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function. Nephron,1996, 72(4) 530-535 被引量:1
  • 8[7]Goodman WG, Goldin J, Kuizon BD, et al. cornary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J med, 2000,342:1478-1483 被引量:1
  • 9[8]Chertow GM, Burke SK, Dillon MA, et al. Lond-term effects of Senelamer hydrochloride on calcium × phosphate product and lipid profile of haemodialysis patients. Nephrol dial Transplant,1999,14:2907-2914 被引量:1
  • 10[9]Slatopolsky EA, Broke SK, Dillon MA. renaGell,a nonabsorbed calcium- and alminumfree phosphate binder, lowers serum phosphorus and parathyroid hormone: the RenaGell Study Group. Kindey int, 1999,55:299-307 被引量:1

共引文献36

同被引文献23

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部